BioFlorida Educates Florida Legislators on Ways to Grow and Promote the State’s Biotechnology Industry 0
BioFlorida Educates Florida Legislators on Ways to Grow and Promote the State’s Biotechnology Industry
BioFlorida hosted its 4th Annual BioFlorida Legislative Day in Tallahassee on Feb. 16 to address the concerns and future needs of Florida’s biotechnology and life science companies.
Read more on Business Wire via Yahoo! Finance
Daniel Reda – An Introduction to Biotechnology and Bioinformatics 17
Intnl. Biotechnology – Net Asset Value(s) 0
Intnl. Biotechnology – Net Asset Value(s)
Intnl. Biotechnology – Net Asset Value(s)
Read more on AFX CNF Finance Regulatory News via Yahoo! UK & Ireland Finance
EuropaBio Event: The Role of Biotechnology in Europe’s Responsible Innovation 0
On Thursday 9 Dec. 2010, a broad range of regulators, CEOs, VCs, stakeholders, industry representatives and journalists met to share their perspectives on the role of biotechnology in contributing to the creation of Europe’s Innovation Union. Speakers from across Europe in the healthcare, industrial and agricultural sectors communicated their views on how biotechnology is creating more jobs, improving lives and building a greener and healthier society. They outlined how these changes are being made through benefits in major areas of concern for European citizens including healthy living and ageing, climate change and food and energy security. Speaking at the event, EuropaBio Chairman, Andrea Rappagliosi said: “Biotechnology has the potential to help make Europe a world-class science performer providing smart, sustainable and inclusive solutions for citizens, patients and consumers for 2020 and beyond. Our industry is willing to be held accountable for delivering products and solutions that have a demonstrable value in order to retain and strengthen state-of-the-art research and development in Europe. We are committed to playing our role in this process together with regulators, civil society and a broad range of stakeholders.” In a video address, specially prepared for the event, President Barroso underlined that “Europe needs an innovative R&D oriented and responsible biotech industry. An industry which is rooted in the middle of our societies, because it offers concrete …
Biotechnology Developments And Stock Ideas From RBC Capital Markets From Last April: Did We Listen To Dr. Jason Kantor … 0
Biotechnology Developments And Stock Ideas From RBC Capital Markets From Last April: Did We Listen To Dr. Jason Kantor …
67 WALL STREET, New York – December 16, 2010 – The Wall Street Transcript has just published its 2010 Health Care Review. This 400 page special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online .
Read more on Wall Street Transcript via Yahoo! Finance
Biotechnology College Jaipur, Biotechnology Research & Development in Jaipur, Rajasthan 0
Dr. B.Lal Biotechnology College in Jaipur offers Biotechnology Research & Development, Clinical Research, Paramedical courses, B.Sc. Biotechnology, B.Sc. Biotechnology, M.Sc. Biotechnology, M.Sc. Clinical Microbiology, Pharma biotechnology and Biotech summer and industrial training program in Jaipur
Trasgenic Crops Fastest Growing Sector in $12 bn Agricultural Biotechnology Market 0
Trasgenic Crops Fastest Growing Sector in $12 bn Agricultural Biotechnology Market
The agricultural biotechnology market is expected to hit $12 billion in 2015, driven by improved crop yield and productivity, cost reduction and the development of pest and diseases resistant crops. Additional factors are fuelling demand for agricultural biotechnology, including food shortages, declining water supplies in certain regions, and changeable environmental conditions in different …
Read more on PRWeb via Yahoo! News
Research and Markets: Biosimilars – The Future Transformation of Product Exclusivity in the Biotechnology Arena 0
Research and Markets: Biosimilars – The Future Transformation of Product Exclusivity in the Biotechnology Arena
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/c70ef7/biosimilars_the) has announced the addition of the “Biosimilars – The Future Transformation of Product Exclusivity in the Biotechnology Arena” report to their offering. The nature of biotechnology has, up until recently, prevented the threat of generic intrusion on product …
Read more on Business Wire
Roche’s Rejects May Again Rejuvenate Swiss Biotechnology Startup Companies 0
Roche’s Rejects May Again Rejuvenate Swiss Biotechnology Startup Companies
Roche Holding AG ’s plan to reduce costs may cast off drug discovery projects, providing a boost to Switzerland’s ailing biotechnology industry and venture capitalists seeking to create health-care companies.
Read more on Bloomberg
